Chronic Pain Management

Supporting the Full Spectrum of Chronic Pain Treatment

Cordant Health Solutions® offers unique pharmacy services, testing platforms and risk monitoring tools that provide actionable data that help to protect providers, hold patients accountable to treatment plans and improve outcomes.

Integrating pharmacy data with laboratory results increases visibility into medication compliance and enables early detection of patient risk factors, allowing for earlier and more effective interventions and better patient outcomes.

Expect More From Your Lab

Learn What Makes Cordant a Comprehensive Chronic Pain Solution

Cordant CORE™ Drug Testing

Until CORE, most physicians were not able to distinguish between patients taking only some of their medication and patients taking their medication as prescribed. The CORE test is the first patient monitoring tool to use saliva samples to help prescribers review whether a medication is present at a level consistent with the prescribed dosing regimen.

Extensive Drug Testing Menu

Testing available for more than 180 metabolites and parent drugs

Mental Health Test Panel

Cordant currently has one of the most extensive mental health testing menus, with the ability to test for 62 mental health medications. Of these, 55 can be tested for using saliva.

Integrated Risk Management Reports

Integrated risk management reports allow you to easily monitor your testing protocols and ensure you are following them as you see appropriate, helping to protect you and offer better care for your patients.

Easy-to-Use Online Lab and State PDMP Integration

Cordant's integrated solutions provide easy access to state prescription drug management program (PDMP) information and increase visibility and insight for prompt intervention, which helps prescribers meet state requirements and leads to improved patient compliance into treatment programs.

Improved Medication Adherence

Analysis of Cordant’s program revealed improved drug testing results with the utilization of protocol management reporting tools.

Over the past 2 years, samples demonstrating unexpected results due to unexpected drugs testing positive and/or prescribed medications not being detected from 49% to 36%.

n=440 and n=283 samples tested for health system’s primary care center in Q1 2017 and Q4 2018, respectively

0 %

Percentage of patients who showed improved medication compliance after initial inconsistent test

Analysis of 487 patients in Cordant’s integrated program for 6+ months; Oct. 2017–Oct. 2018

0 k+

Pills not dispensed due to pharmacist and prescriber interaction prior to fill

Analysis of Cordant pharmacy program; Jan.–Dec. 2018

0 %

Decrease in MME values for patients receiving both pain medication from Cordant’s pharmacy and routine risk assessments

Case study of 983 pain patients in Cordant’s pharmacy program; Dec. 2016–July 2018

What Our Clients Are Saying

By combining detailed pharmacy reports with drug testing results, we can identify patients who have a higher risk for misuse and therefore would benefit from greater intervention.

I am able to have better conversations with my patients when I have CORE results to discuss. Specifically, I just had a patient that was below the expected range with CORE. It turns out he was only consistently taking four of the six pills I prescribed daily. CORE helped me reduce the number of pills I was prescribing, while most importantly, ensuring appropriate patient care.